Code | 9685B | ||||||||||
MA number | 21/0728/11-S | ||||||||||
Product Form: | tbl flm 20x1000 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 25.11.2011 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Levetiracetam Sandoz 1000 mg_01.2023.pdf |
SPC: | SPC_Levetiracetam Sandoz 1000 mg_01.2023.pdf |
Safety feature | Yes |
Data update: | 29.05.2018 |